ATE60231T1 - Unloesliches arzneimittel das lokal im ohr verabreicht wird. - Google Patents

Unloesliches arzneimittel das lokal im ohr verabreicht wird.

Info

Publication number: ATE60231T1
Authority: AT; Austria
Prior art keywords: ear; insoluble drug; drug delivered; delivered locally; insoluble
Prior art date: 1984-11-14

Application number

AT85402107T

Other languages

English (en)

Inventor

Georges Serge Grimberg

Henri Andre Martin

Maurice Carraz

Original Assignee

Georges Serge Grimberg

Henri Andre Martin

Mallein Rene

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-11-14

Filing date

1985-10-31

Publication date

1991-02-15

1985-10-31 Application filed by Georges Serge Grimberg, Henri Andre Martin, Mallein Rene filed Critical Georges Serge Grimberg

1991-02-15 Application granted granted Critical

1991-02-15 Publication of ATE60231T1 publication Critical patent/ATE60231T1/de

Links

239000003814 drug Substances 0.000 title abstract 2
229940079593 drug Drugs 0.000 title 1
239000002260 anti-inflammatory agent Substances 0.000 abstract 1
229940121363 anti-inflammatory agent Drugs 0.000 abstract 1
230000003110 anti-inflammatory effect Effects 0.000 abstract 1
239000004599 antimicrobial Substances 0.000 abstract 1
229960000988 nystatin Drugs 0.000 abstract 1
VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 abstract 1
239000000843 powder Substances 0.000 abstract 1
239000000725 suspension Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0046—Ear
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Dispersion Chemistry (AREA)
Molecular Biology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

AT85402107T 1984-11-14 1985-10-31 Unloesliches arzneimittel das lokal im ohr verabreicht wird. ATE60231T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR8417397A FR2572932B1 (fr)	1984-11-14	1984-11-14	Medicament insoluble administre localement dans l'oreille
EP85402107A EP0182696B1 (de)	1984-11-14	1985-10-31	Unlösliches Arzneimittel das lokal im Ohr verabreicht wird

Publications (1)

Publication Number	Publication Date
ATE60231T1 true ATE60231T1 (de)	1991-02-15

Family

ID=9309603

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT85402107T ATE60231T1 (de)	1984-11-14	1985-10-31	Unloesliches arzneimittel das lokal im ohr verabreicht wird.

Country Status (7)

Country	Link
US (1)	US4938959A (de)
EP (1)	EP0182696B1 (de)
JP (1)	JPH085778B2 (de)
AT (1)	ATE60231T1 (de)
CA (1)	CA1260831A (de)
DE (1)	DE3581500D1 (de)
FR (1)	FR2572932B1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5954682A (en) *	1996-09-25	1999-09-21	Advanced Medical Instruments	Therapeutic applicator apparatus and method
US20080299179A1 (en) *	2002-09-06	2008-12-04	Osman Rathore	Solutions for ophthalmic lenses containing at least one silicone containing component
US20070078116A1 (en) *	2003-08-20	2007-04-05	Fairfield Clinical Trials, Llc	Method of treatment of otitis externa
US20050043251A1 (en) *	2003-08-20	2005-02-24	Fairfield Clinical Trials, Llc	Method of treatment of otitis externa
US20070264362A1 (en) *	2006-05-11	2007-11-15	Nina Yoshpe	Method and composition for treating ear inflammation caused by dry ear

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2797183A (en) *	1952-01-07	1957-06-25	Research Corp	Nystatin and method of producing it
US4025620A (en) *	1975-10-22	1977-05-24	Leo Pharmaceutical Products Ltd., A/S	Treatment of canine otitis and composition therefor
FR2542616B1 (fr) *	1983-03-17	1987-07-31	Unilever Nv	Composition pour le traitement des muqueuses a base d'un antibiotique et d'un hydrocolloide formateur de gel

1984
- 1984-11-14 FR FR8417397A patent/FR2572932B1/fr not_active Expired
1985
- 1985-10-31 EP EP85402107A patent/EP0182696B1/de not_active Expired - Lifetime
- 1985-10-31 DE DE8585402107T patent/DE3581500D1/de not_active Expired - Lifetime
- 1985-10-31 AT AT85402107T patent/ATE60231T1/de not_active IP Right Cessation
- 1985-11-08 CA CA000494866A patent/CA1260831A/en not_active Expired
- 1985-11-13 JP JP60254638A patent/JPH085778B2/ja not_active Expired - Lifetime
1988
- 1988-08-30 US US07/239,340 patent/US4938959A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
EP0182696A1 (de)	1986-05-28
JPS61178914A (ja)	1986-08-11
DE3581500D1 (de)	1991-02-28
CA1260831A (en)	1989-09-26
US4938959A (en)	1990-07-03
JPH085778B2 (ja)	1996-01-24
FR2572932B1 (fr)	1987-01-23
FR2572932A1 (fr)	1986-05-16
EP0182696B1 (de)	1991-01-23

Similar Documents

Publication	Publication Date	Title
NL300045I1 (nl)	2001-08-01	Fluorcytidine-derivaten, de bereiding daarvan en geneesmidddelen die deze derivaten bevatten.
DK183386A (da)	1986-04-21	Sucralfatsuspension
DE3583799D1 (de)	1991-09-19	Feste zubereitung mit langsamer freisetzung.
GR3004531T3 (de)	1993-04-28
DE69109557D1 (de)	1995-06-14	Überzogene feste Arzneiform mit Verabreichungsmöglichkeit im Dickdarm.
IT8847582A0 (it)	1988-01-29	Composizione orale antibatterica, antiplacca ed antitartaro
IT8219730A0 (it)	1982-02-18	Derivati 5-amminometil-ossazolidinici, procedimento per la loro preparazione, e loro applicazione in terapia.
NZ237790A (en)	1993-12-23	Substituted benzimidazoles and medicaments.
AU7766787A (en)	1988-03-03	Arylcarboxylic acid derivatives, the preparation and use thereof
AU7378987A (en)	1987-12-10	Drug delivery device, its preparation and use
IT1230703B (it)	1991-10-29	Derivati imidazolonici ad attivita' antiipertensiva, loro metodi di preparazione e composizioni farmaceutiche che li contengono.
IL84913A0 (en)	1988-06-30	Alkanesulfonanilide derivatives,processes for preparation thereof and pharmaceutical composition comprising the same
NO881760L (no)	1988-10-25	Aminoalkylerte polyakrylamidaldehydgeler, fremstilling oganvendelse derav i oljeutvinning.
DE3776620D1 (de)	1992-03-19	3-propenylcephemderivate, ihre herstellung, zwischenverbindungen, pharmazeutische praeparate und anwendung.
EP0230264A3 (en)	1988-12-14	Pharmaceutical composition for nasal application, process for its preparation and its use
ATE60231T1 (de)	1991-02-15	Unloesliches arzneimittel das lokal im ohr verabreicht wird.
AU575711B2 (en)	1988-08-04	2-(4,5-dihydro-1h-imidazol-2-yl)-2,3-dihydroindole derivatives the preparation therof and their application in therapy
IL78357A0 (en)	1986-07-31	Nitrofuran derivatives,the preparation thereof and their application in therapy
IT8323925A0 (it)	1983-11-28	Derivati bezilidenici solforati, loro preparazione e loro applicazione in terapia.
FI883484A7 (fi)	1989-01-24	Bentsimidatsolijohdannaiset, niiden valmistus ja käyttö terapiassa.
EP0246861A3 (en)	1989-01-04	Pharmaceutical composition based on crotoxine, process for preparing the active component and the pharmaceutical composition
IT8224306A0 (it)	1982-11-17	Derivati benzilidenici, loro preparazione e loro applicazione in terapia.
ZA913171B (en)	1992-02-26	1,5-benzothiazepinone derivatives,their preparations and pharmaceutical use
AU3114189A (en)	1989-09-28	2-imidazolylmethyl-1,3-dioxolanyl methylthiophenyl carbamate derivatives and their use as antineoplastic agents
EP0419157A3 (en)	1991-08-28	Pharmacologically active compound., preparation and use

Legal Events

Date	Code	Title	Description
1991-10-15	UEP	Publication of translation of european patent specification
1998-07-15	REN	Ceased due to non-payment of the annual fee